AUG 01, 2019 12:57 PM PDT

How cancer tricks our immune systems

Research published yesterday in Nature details the finding of a new “Don’t eat me” signal that cancers use to hide from the body’s immune system. Previous proteins with a similar role have been identified in past studies, but the discovery of this new protein, called CD24, may lead the way to novel anti-cancer therapies. The study comes from researchers at the Stanford University School of Medicine.

CD24 is one of several other proteins including PD-L1, CD47 and the beta-2-microglobulin subunit of the major histocompatibility class 1 complex that allow cancer cells to essentially evade immune cells called macrophages that are tasked with destroying unwanted pathogens. Based on that previous research, several cancer treatments that block or target the previously found proteins are already in clinical trials.

Senior author Irving Weissman, MD, professor of pathology and of developmental biology and director of the Stanford Institute for Stem Cell Biology and Regenerative Medicine explained that "Finding that not all patients responded to anti-CD47 antibodies helped fuel our research at Stanford to test whether non-responder cells and patients might have alternative 'don't eat me' signals.”

In the study, the researchers discovered that many cancers produce an abundance of CD24 compared with normal cells and surrounding tissues. They were clued in to look for the proteins because of the implication it has. Lead author Amira Barkal explains: "You know that if cancers are growing in the presence of macrophages, they must be making some signal that keeps those cells from attacking the cancer. You want to find those signals so you can disrupt them and unleash the full potential of the immune system to fight the cancer."

Photo: Pixabay

To test their findings, the research team implanted human breast cancer cells in mice and determined that blocking CD24 signaling in the cancer cells resulted in the mice’s immune system macrophages attacking the cancer cells. "When we imaged the macrophages after treating the cancers with CD24 blockade, we could see that some of them were just stuffed with cancer cells," Barkal said.

The team hopes to continue investigating these signals with the hope that their findings will evolve into even more available anti-cancer therapies. "There are probably many major and minor 'don't eat me' signals, and CD24 seems to be one of the major ones," Barkal said. The findings may have particular impact on ovarian and triple-negative breast cancer, both of which responded well to blocking CD24. “This may be a vulnerability for those very dangerous cancers," added Barkal.

Sources: Science Daily, Nature

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
AUG 18, 2021
Technology
Tracking System Maps How Cancer Cells Evolve, Providing New Treatment Insights
AUG 18, 2021
Tracking System Maps How Cancer Cells Evolve, Providing New Treatment Insights
All cells in a tumor share some genetic similarities, but also have key differences, often hindering effective treatment ...
AUG 29, 2021
Cancer
Blood Test over 90% Accurate in Detecting Lung Cancer
AUG 29, 2021
Blood Test over 90% Accurate in Detecting Lung Cancer
An AI-powered blood test was able to correctly detect the presence of lung cancer over 90% of the time in patient sample ...
SEP 09, 2021
Cancer
Can a Mole Fight Melanoma?
SEP 09, 2021
Can a Mole Fight Melanoma?
About 30% of melanoma cases arise from an existing nevus.  More commonly known as moles, Nevi are skin growths that ...
OCT 01, 2021
Health & Medicine
Eppendorf Award 2022: Call for Entries
OCT 01, 2021
Eppendorf Award 2022: Call for Entries
Eppendorf Award 2022: Call for Entries The Eppendorf Award for Young European Investigators, endowed with 20,000 EUR, is ...
OCT 21, 2021
Cancer
Exercise: A Secret Weapon to Combat Prostate Cancer?
OCT 21, 2021
Exercise: A Secret Weapon to Combat Prostate Cancer?
Exercise oncology is an evolving science that considers the addition of physical activity regimens to the treatment ...
NOV 04, 2021
Cancer
Giving the Immune System a Kickstart to Improve Immunotherapy Efficacy
NOV 04, 2021
Giving the Immune System a Kickstart to Improve Immunotherapy Efficacy
Despite the incremental success immune checkpoint inhibitors (ICI) have attributed to the cancer treatment landscape rec ...
Loading Comments...